1. Home
  2. MYGN vs LION Comparison

MYGN vs LION Comparison

Compare MYGN & LION Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.28

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$9.16

Market Cap

2.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
LION
Founded
1991
1997
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
481.6M
2.4B
IPO Year
1996
2025

Fundamental Metrics

Financial Performance
Metric
MYGN
LION
Price
$4.28
$9.16
Analyst Decision
Buy
Buy
Analyst Count
8
9
Target Price
$7.64
$10.19
AVG Volume (30 Days)
1.7M
2.2M
Earning Date
05-05-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$771,400,000.00
$3,195,500,000.00
Revenue This Year
$6.89
N/A
Revenue Next Year
$5.35
$22.98
P/E Ratio
N/A
N/A
Revenue Growth
2.33
7.00
52 Week Low
$3.76
$5.65
52 Week High
$8.63
$11.02

Technical Indicators

Market Signals
Indicator
MYGN
LION
Relative Strength Index (RSI) 36.52 45.68
Support Level $4.24 $6.46
Resistance Level $5.69 $9.54
Average True Range (ATR) 0.32 0.39
MACD -0.02 -0.08
Stochastic Oscillator 2.96 3.25

Price Performance

Historical Comparison
MYGN
LION

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

Share on Social Networks: